Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism PKCδ inhibitors(Protein kinase C delta inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC26H23NO2 |
InChIKeyQLDDENZBVHBRKN-UHFFFAOYSA-N |
CAS Registry1564249-38-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Melanoma | Preclinical | US | 18 Feb 2014 |